1
Palonosetron Plus Aprepitant Versus Palonosetron in Preventing Nausea and Vomiting in Leukemic Patients
Condition(s):Chemotherapy Induced Nausea and VomitingLast Updated:July 31, 2014Unknown status
Palonosetron as an Intervention: 131 Clinical Trials, Page 1 of 14
Hide Studies Not Open or Pending
2
Intravenous Palonosetron With Radiotherapy and Concomitant Temozolomide
Condition(s):Malignant GliomaLast Updated:August 28, 2019Completed
3
Buccal Film vs IV Palonosetron for Prevention of CINV in Cancer Patients Receiving MEC
Condition(s):Chemotherapy-induced Nausea and VomitingLast Updated:January 20, 2023Recruiting
4
Compare Between Two Doses of Palonosetron on the Prevention of Postoperative Nausea and Vomiting in Obese Patients
Condition(s):Postoperative Nausea and VomitingLast Updated:August 7, 2018Completed
5
Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Palonosetron in Cancer Treated With Chemotherapy
Condition(s):EmesisLast Updated:January 27, 2015Completed
6
Intensive Medicines Monitoring Project of Palonosetron Hydrochloride Capsules (Ruo Shan®)
Condition(s):PalonosetronLast Updated:May 11, 2017Unknown status
7
The Safety and Effectiveness of Palonosetron Hydrochloride Capsule Was Used to CINV
Condition(s):Nausea and VomitingLast Updated:January 19, 2023Recruiting
8
Combination of Netupitant and Palonosetron (Akynzeo®) in the Treatment of Refractory CINV
Condition(s):Chemotherapy Induced Nausea VomitingLast Updated:December 9, 2019Terminated
9
Palonosetron for the Treatment of Nausea and Vomiting in Terminally Ill Patients
Condition(s):Nausea; Vomiting; Terminally IllLast Updated:December 4, 2015Terminated
10
NEPA to Prevent Chemotherapy Induced Nausea and Vomiting in Patients With Breast Cancer
Condition(s):Chemotherapy-induced Nausea and VomitingLast Updated:March 5, 2019Completed